헤모글로빈 검사 세계 시장 규모는 2024년 25억 5,000만 달러에 달했습니다. 향후 IMARC Group은 이 시장이 2033년까지 41억 2,000만 달러에 달하고, 2025-2033년 5.22%의 연평균 성장률(CAGR)을 보일 것으로 전망하고 있습니다. 당뇨병, 빈혈과 같은 만성 질환 증가가 시장을 자극하고 있습니다.
포인트 오브 케어 검사에 대한 수요 증가
현장 검사(POCT)로의 전환은 기존 검사실 이외의 장소에서 빠르고 편리한 검사를 제공하기 때문에 헤모글로빈 모니터링 시장에서 중요한 발전입니다. 휴대용 분석기는 빠른 결과를 제공하여 환자 관리 및 의사 결정을 개선합니다. 2024년 6월, 호리바는 새로운 소형 혈액학 분석기인 Yumizen H550E(오토로더), H500E CT(폐쇄형 튜브), Yumizen H500E OT(개방형 튜브)를 출시하였습니다. 전혈에서 60초 만에 CBC/DIFF와 ESR 결과를 복합적으로 검사할 수 있습니다.
진단에 인공지능(AI) 활용 확대
헤모글로빈 검사 시장 개요에서는 정확성과 효율성을 높이기 위해 헤모글로빈 검사에 빠르게 활용되고 있는 AI에 대해 알아봅니다. AI가 탑재된 시스템은 대규모 데이터 세트를 신속하게 평가하고, 인적 오류를 최소화하며, 진단 정확도를 향상시킬 수 있습니다. 이것은 헤모글로빈 검사 시장 성장 촉진요인 중 하나입니다. 2024년 8월, IIT 카라그푸르가 사티야 사이 병원과 공동으로 AI를 활용한 빈혈 검진을 실시했습니다. 이 공동연구는 소외계층의 빈혈 문제를 해결하기 위한 혁신적인 솔루션 개발에 초점을 맞추었습니다.
빈혈에 대한 인식 개선 및 검진
헤모글로빈 농도 감소를 동반하는 질환인 빈혈의 조기 발견이 점점 더 중요해지고 있습니다. 전 세계 정부와 보건 기관은 임산부, 어린이 등 빈혈에 취약한 사람들의 빈혈을 확인하기 위한 선별 검사 프로그램을 시작하고 있습니다. 2024년 2월, 인도 소아과학회(IAP)는 빈혈 및 기타 중요한 아동 건강 문제에 대한 인식을 높이기 위해 전국적인 캠페인을 시작했습니다.
The global hemoglobin testing market size reached USD 2.55 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 4.12 Billion by 2033, exhibiting a growth rate (CAGR) of 5.22% during 2025-2033. An increase in chronic conditions, including diabetes and anemia, is stimulating the market.
Rising Demand for Point-of-Care Testing
The shift to point-of-care testing (POCT) is a significant development in the hemoglobin monitoring market as it provides quick, convenient testing outside of traditional labs. Portable analyzers deliver quick results, which improves patient care and decision-making. In June 2024, Horiba launched new compact hematology analyzers, namely, Yumizen H550E (autoloader), H500E CT (closed tube), and Yumizen H500E OT (open tube). They offer combined testing for CBC/DIFF with ESR results from whole blood in 60 seconds.
Growing Use of Artificial Intelligence (AI) in Diagnostics
The hemoglobin testing market overview is exploring AI, which is rapidly being used in hemoglobin testing to improve accuracy and efficiency. AI-powered systems can swiftly evaluate big datasets, minimizing human error and improving diagnosis accuracy. This is one of the hemoglobin testing market drivers. In August 2024, IIT Kharagpur collaborated with Sathya Sai Hospital for AI-powered anemia screening. This joint effort focuses on developing innovative solutions to address the challenges of anemia in underprivileged populations.
Increasing Awareness and Screening for Anemia
Early identification of anemia, a disorder associated with low hemoglobin levels, is becoming increasingly important. Governments and health organizations around the world are launching screening programs to identify anemia in susceptible populations, such as pregnant women and children. In February 2024, the Indian Academy of Pediatrics (IAP) launched a nationwide campaign to raise awareness about anemia and other crucial child health issues.
As per the hemoglobin testing market share analysis, reagents and consumables, such as test strips and other disposable materials, have a strong presence in the market due to their widespread use in diagnostic procedures. The equipment segment, which includes analyzers and point-of-care devices, is experiencing considerable growth due to technical developments and rising demand for portable testing solutions.
Chromatography is frequently utilized for precise and thorough hemoglobin variant analysis, especially in laboratory settings where precision is crucial. Meanwhile, immunoassay technology is gaining popularity because of its speed and cost-effectiveness, making it ideal for point-of-care testing and routine hemoglobin monitoring in a variety of healthcare settings. These segments are contributing to shaping hemoglobin testing market dynamics.
According to the hemoglobin testing industry statistics, laboratories hold a considerable proportion due to their ability to do high-volume testing and extensive analysis. Hospitals play an important role in hemoglobin testing for patient diagnosis and monitoring. Moreover, research institutions contribute to market growth by developing new testing methods and diagnostic technologies.
The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America, Europe, Asia Pacific, the Middle East and Africa, and Latin America.
As per the hemoglobin testing market outlook, advanced healthcare systems and extensive diagnostic tool usage are pushing the market in North America. Europe benefits from strong government healthcare assistance and heightened awareness of early detection. Asia Pacific is experiencing rapid growth due to its large population, rising healthcare awareness, and improving medical infrastructure. In Latin America, the market is growing as healthcare systems improve and focus on malnutrition-related illnesses. The Middle East and Africa region is evolving, with more access to healthcare, increased investment in diagnostics, and initiatives to tackle regional health challenges such as anemia.